Makiko Nagai

Title: Makiko Nagai: Innovator in Stem Cell Research

Introduction

Makiko Nagai is a prominent inventor based in Okayama, Japan. She has made significant contributions to the field of stem cell research, particularly in developing innovative culture systems for drug development. Her work focuses on addressing degenerative nervous system disorders, which are critical areas of medical research.

Latest Patents

Makiko Nagai holds a patent for a "Stem cell-based culture system for drug development." This invention relates to culture systems comprising differentiated stem cells that can be utilized for identifying agents useful in treating degenerative nervous system disorders. The system is designed for high-throughput screening applications and is based on the discovery that co-cultures of astrocytes expressing a mutated SOD1 gene and stem-cell derived motor neurons exhibit cell death via a Bax-dependent mechanism. This model effectively simulates motor neuron death in amyotrophic lateral sclerosis.

Career Highlights

Nagai's career is marked by her dedication to advancing stem cell technology and its applications in medicine. She is affiliated with Columbia University, where she continues her research and development efforts. Her innovative approach has garnered attention in the scientific community, contributing to the understanding of neurodegenerative diseases.

Collaborations

Throughout her career, Makiko Nagai has collaborated with esteemed colleagues, including Hynek Wichterle and Serge Przedborski. These collaborations have further enriched her research and expanded the impact of her work in the field of stem cell research.

Conclusion

Makiko Nagai is a trailblazer in the realm of stem cell research, with her patented innovations paving the way for advancements in drug development for neurodegenerative disorders. Her contributions are vital to the ongoing efforts to find effective treatments for these challenging conditions.